MCET Stock UPDATES Multicell Techs Inc (MCET) 0.0007 08/03/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Multicell Techs Inc (MCET) 0.0007 $MCET

MultiCell Technologies files patent applications for MCT-485
M2 - Fri Mar 21, 7:01AM CDT
US-based biopharmaceutical company MultiCell Technologies (OTC BB:MCET) revealed on Thursday that it has submitted applications for additional US and international patents covering MCT-485 and its composition of matter, biological targets, mechanism of action and methods and formulations for therapeutic use.

Groupon and SF-Marin Food Bank to Present "One Groupon One Meal" Campaign; MultiCell Technologies Files Patent Applications
ACCESSWIRE - Thu Mar 20, 11:27PM CDT
Walter Energy, Inc. (NYSE: WLT) - For an in-depth report on Walter Energy, Inc. follow: www.BullTrends.com/stockquote/WLT

MultiCell Technologies Files U.S. and International Patent Applications for the Treatment of Liver Cancer
PR Newswire - Thu Mar 20, 7:39AM CDT
MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has filed additional U.S. and international patent applications covering MCT-485 and its composition of matter, biological targets, mechanism of action, and methods and formulations for therapeutic use.

eLayaway Inc. Share Price Soars 75 Percent
ACCESSWIRE - Mon Mar 17, 8:50AM CDT
March 17, 2014 / eLayaway Inc. (OTCQB: ELAY) share volume skyrocketed Mar. 14, with 1,232,461,409 shares changing hands, nearly nine times its three-month average volume of 138,035,702 shares.

MultiCell Technologies Seeks Patent for Cancer-Fighting Technology
ACCESSWIRE - Tue Mar 04, 9:03AM CST
MultiCell Technologies Inc. (OTCQB: MCET) stock volume soared Mar. 3, with 41,190,256 shares changing hands, significantly higher than its three-month average volume of 30,444,778 shares.

MultiCell Technologies Inc files patent application for new class of RNA Therapeutics, VSRNAs
M2 - Thu Jan 16, 4:40AM CST
Biopharmaceutical company MultiCell Technologies Inc (OTC BB:MCET.OB) reported on Wednesday the submission of a US provisional patent application covering the composition of matter, biological targets, mechanism of action, methods and formulations to achieve targeted tumor cell death.

MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics
PR Newswire - Wed Jan 15, 7:39AM CST
MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) has filed a U.S. provisional patent application concerning composition of matter, biological targets, mechanism of action, methods and formulations to achieve targeted tumor cell death.

OTC Daily Alert Stock Watch - MultiCell Technologies, Inc. (OTCQB: MCET)
WorldStockWire - Thu Sep 05, 4:15PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer
PR Newswire - Tue Aug 06, 7:00AM CDT
MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) and Genisphere LLC will collaborate on the development of targeted MCT-485 nanoparticle therapeutics for the treatment of liver cancer. MCT-485 is a noncoding double stranded micro RNA (miRNA) which has demonstrated oncolytic and immune stimulating activity in in vitro models of hepatocellular carcinoma.

MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer
PR Newswire - Thu May 16, 7:00AM CDT
MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) is pleased to announce the filing of a U.S. patent application concerning methods and formulations to achieve targeted tumor cell death. MCT-485 is a noncoding double stranded micro RNA (miRNA) which has demonstrated oncolytic and immune stimulating activity in in vitro models of hepatocellular carcinoma.

MultiCell Technologies and Federal National Mortgage Association Review: (OTCQB: MCET), (OTCQB: FNMA)
ACCESSWIRE-TNW - Sun Mar 03, 4:29PM CST
New York (March 3rd, 2013) - MultiCell Technologies, Inc. (OTCQB: MCET) Files SEC form 10-K, Annual Report.

Medical Marijuana and MultiCell Technologies News: (OTC Pink: MJNA), (OTCQB: MCET)
ACCESSWIRE-TNW - Fri Mar 01, 1:21AM CST
New York (March 1st, 2013) - Medical Marijuana, Inc. (OTC Pink: MJNA) a leading cannabis and hemp industry innovator provided a comprehensive update to shareholders on the state of the medical cannabis and hemp industry. Many legislative actions have occurred, particularly since the November elections, which are providing significant positive momentum in our rapidly expanding markets.

China Teletech Holding and MultiCell Technologies Trend Analysis Reports: (OTCQB: CNCT), (OTCQB: MCET)
ACCESSWIRE-TNW - Tue Feb 26, 1:58AM CST
New York (February 26th, 2013) - China Teletech Holding, Inc. (OTCQB: CNCT) last traded at $0.215, down $-0.069 or 24.30%. The stock has a 52 week range of $0.00 - $0.47. In the last session the stock traded a volume of 26.58M versus a 30 day average of 843,675.

AMR Corp Announcement & MultiCell Technologies Bullish Momentum: (OTCQB: AAMRQ), (OTCQB: MCET)
ACCESSWIRE-TNW - Wed Feb 20, 12:06AM CST
New York (February 20th, 2013) - AMR Corporation (OTCQB: AAMRQ), the parent company of American Airlines, Inc., and US Airways Group, Inc. (LCC) announced last week that the boards of directors of both companies have unanimously approved a definitive merger agreement under which the companies will combine to create a premier global carrier, which will have an implied combined equity value of approximately $11 billion based on the price of US Airways' stock as of February 13, 2013.

MultiCell Technologies presents abstract at 2012 ASCB Meeting
M2 - Thu Dec 27, 8:39AM CST
MultiCell Technologies Inc (OTCBB: MCET), a clinical-stage biopharmaceutical company, said on Wednesday that at the 2012 American Society for Cell Biology (ASCB) Annual Meeting, being held in San Francisco, California, Simona Bot, MD on Tuesday presented preclinical research results in an abstract titled 'Short Synthetic Double Stranded RNA with Dual Activity - Oncolytic and Immune Modulatory - for Hepatocellular Carcinoma'.

MultiCell Technologies Delivered Presentation at 2012 ASCB Meeting
PR Newswire - Wed Dec 26, 7:00AM CST
MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) presented at the 2012 American Society for Cell Biology® (ASCB®) Annual Meeting in San Francisco, CA, on Tuesday, December 18. Simona Bot, M.D. presented preclinical research results in an abstract titled "Short Synthetic Double Stranded RNA with Dual Activity - Oncolytic and Immune Modulatory - for Hepatocellular Carcinoma."



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Katahdin's Portland Branch Bet Moves Downtown in 2027

Updated Category News Views 61

Exchange Street is getting a real-world vote of confidence, and that is more interesting than another app update ever will be. Katahdin Trust intends to open a full-service branch at 120 Exchange Street in downtown Portland, with renovations slated to begin early in 2027 and an opening expected later that year. For a Maine community bank with nearly $1.2 billion in...

Continue Reading
Washington-to-Asia Advisory Deal Targets Policy Risk

Updated Category News Views 10

Policy bottlenecks are becoming a cost center across Southeast Asia. That is the plain-English backdrop for the strategic partnership announced November 18, 2026, by Beacon Global Strategies and Vriens & Partners. Neither firm is selling a factory, a chip design, or a new energy project. They are selling something companies increasingly cannot afford to improvise: a...

Continue Reading
APEC's Shared-Prosperity Message Needs More Detail

Updated Category News Views 20

Geese make handsome symbols, but markets cannot underwrite a metaphor. The Nov. 18, 2026 report from Xinhua News Agency looks back to remarks Chinese President Xi Jinping made 12 years ago, when he used swan geese to urge APEC economies toward greater cooperation and a new collective flight. Its present-day message is plainly hopeful: the APEC family is moving across the...

Continue Reading
CVRx Lawsuit Deadline Follows a Brutal 59.76% Plunge

Updated Category News Views 24

A 59.76% one-day wipeout has a way of stripping the varnish off every upbeat corporate story. For CVRx investors, the hard fact is that the shares fell $3.55 to close at $2.39 on August 7, 2026, after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That kind of disclosure does not merely dent confidence; it forces...

Continue Reading
Haemonetics Opens Europe for VASCADE MVP XL Device

Updated Category News Views 31

A larger collagen plug is hardly cocktail-party material, yet it can matter a great deal when it sits inside a procedure workflow hospitals are trying to speed up. Haemonetics has received CE Mark certification under the EU Medical Device Regulation for VASCADE MVP XL, its larger-bore venous vascular closure system, and first commercial European procedures were completed...

Continue Reading
Fapon’s Enzyme Push Meets Diagnostics Reality at AMP

Updated Category News Views 85

Enzymes rarely get applause at industry meetings, but they can quietly decide whether a diagnostic workflow behaves or becomes a lab headache. Fapon used its AMP 2026 appearance in Seattle to make that unglamorous case: better enzyme design may help assays move faster and keep working when samples get messy. The company wrapped up the November 10–14 meeting after...

Continue Reading
Photocure Opens a New Access Route for Hexvix Patients

Updated Category News Views 31

Forty-plus markets just moved from “not available” toward a workable route for individual bladder cancer patients, and that is the real substance of Photocure’s new arrangement with Clinigen. This is not a sweeping product launch, nor is it an approval announcement dressed up in confetti. It is a Named Patient Program, which matters because the regulatory plumbing...

Continue Reading
Kids First Data Sharing Raises Pediatric Research Bar

Updated Category News Views 68

Thirty-eight thousand children’s records are not a headline gimmick; they are a serious argument for treating research data as an asset that must keep working after the first study ends. The Gabriella Miller Kids First Data Resource Center’s ten-year review, published in the September 2026 issue of The American Journal of Human Genetics, makes that argument with...

Continue Reading
DEFSEC Tackles Nasdaq Bid Price Hurdle with Share Move

Updated Category News Views 68

Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...

Continue Reading
WYBOT's New Robots Push Hands-Free Pool Care in Lyon

Updated Category News Views 0

A pool robot climbing out of the water to dock itself is the sort of demo that makes people stop mid-aisle at a trade show. WYBOT brought precisely that kind of attention-grabber to Piscine Global Lyon 2026, running November 17–20 at Eurexpo Lyon. The company is showing a broader lineup, but the M3 Pro is plainly the headline act: WYBOT calls it the world's first...

Continue Reading

Top 5 Most Recently Viewed Articles

Carrier Global Under Fire: An Investor's Investigation

Updated Category News Views 63

Sometimes the heat in the boardroom can match the heat of a summer's day. Enter Carrier Global Corporation (NYSE: CARR), where a group of folks who should've had their numbers kept tidy started playing with fire. Now there's an invite to a showdown from Schall, Brown & Schwartz LLP. They've thrown down the gauntlet to dig into whether Carrier’s statements could put them...

Continue Reading
Wise Group Faces Class Action Over Misleading Statements

Updated Category News Views 15

Wise Group plc: Legal Storm Brewing on the Horizon Looks like Wise Group's NASDAQ journey might be hitting some turbulence. Shareholders who picked up shares of the NASDAQ ticker WSE between May 11 and July 23, 2026, are getting a nudge to join a class action lawsuit that's gaining steam. Nothing sends a chill down a stockholder’s spine quite like the term "materially...

Continue Reading
FTI Consulting Enhances AI Capabilities with New Leadership

Updated Category News Views 151

FTI Consulting Announces New Senior Director for AI Innovation Global business advisory firm FTI Consulting, Inc. (NYSE: FCN), has recently appointed Brian Knudson as Senior Managing Director in the Data & Technology Transformation practice within the Corporate Finance & Restructuring segment. This strategic hire showcases FTI's commitment to enhancing its capabilities in...

Continue Reading
Viasat Launches Government Services via ViaSat-3 F1 Satellite

Updated Category News Views 156

Viasat Launches Government Services via ViaSat-3 F1 Satellite Viasat is now providing crucial satellite services to the U.S. Marine Corps using the ViaSat-3 network. This launch marks a significant stride towards enhancing connectivity for government operations. Connecting Military Operations The Marine Wing Communications Squadron 38 (MWCS-38) and the 3rd Marine Littoral...

Continue Reading
Automatic Trash Cans: A Game-Changer for Households

Updated Category News Views 87

Tired of Wrestling with Trash Cans? You'd think in this high-tech era, someone would've cracked the code on trash day drudgery. Well folks, the TRASH HAULER might just be the answer. Created by an inventive mind from Manhattan, Kansas, this gizmo is out to revolutionize the way we handle our garbage—by doing the heavy lifting for us on pickup day. The Idea Behind TRASH...

Continue Reading